Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Acute Care Utilization in Pediatric Sickle Cell Disease and Sickle Cell Trait in the USA: Prevalence, Temporal Trends, and Cost
source: European Journal of Pediatrics
year: 2020
authors: Elisha E. Peterson, Jason L. Salemi, Deepa Dongarwar, Hamisu M. Salihu
summary/abstract:The objective of this study was to analyze acute care utilization of sickle cell disease (SCD) and sickle cell trait (SCT) in children and identify trends in emergency department (ED) visits and inpatient admissions over a 10-year period. This is a retrospective population-based study of SCD- and SCT-related ED visits and admissions from 2006 to 2015. Data were acquired from the Healthcare Cost and Utilization Project (HCUP), National Inpatient Sample (NIS), and National Emergency Department Sample (NEDS) database.
Cost-to-charge and estimated professional fee ratios were applied to approximate costs. Over 80% of medical expenditure on HbSS is through ED-based admissions. There is a statistically significant increase from 2006 to 2015 in the direct hospital admissions associated with patients less than 18 years of age who have been diagnosed with SCT.
Conclusion:
Among patients less than 18 years of age with HbSS, inpatient admissions through the emergency department accounted for the largest medical expenditure of the SCD subtypes.
organization: Children’s National Health System, USA ; Baylor College of Medicine, USADOI: 10.1007/s00431-020-03656-x
read more
+myBinderRelated Content
-
Indiana Sickle Cell Conference 2020 – VirtualThis one-day conference will provide hel...
-
Sickle cell trait may not increase the risk of deathPeople who carry a gene for sickle cell ...
-
The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle traitRenal dysfunction is among the most comm...
-
Sickle Cell Trait and Risk of Cognitive Impairment in African Americans: The Reasons for Geographic and Racial Diffe...Background: Sickle cell anemia (SCA) has...
-
Vivien Sheehan, MD, PhDDr. Vivien Sheehan is a pediatric and ad...
-
Punam Malik, MDDr. Punam Malik is a pediatric hematolog...
-
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients Wi...Sancilio Pharmaceuticals Company, Inc. (...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.